drugset / Trial / NCT00001122

A Study of an Adherence Plan to Help HIV-Positive Patients Take Their First Anti-HIV Medications Correctly

NCT00001122 ↗

CrossoverTreatment

Summary

The purpose of this study is to see if observed therapy can help HIV-positive patients stick to their anti-HIV medication schedule. Observed therapy means that a nurse will watch patients take their medications to make sure that they take them correctly. It is very important that HIV-positive patients take their anti-HIV medications correctly so they get the best possible benefit from them. Taking the drugs correctly, called "adherence," may keep HIV virus levels in the blood (viral load) low for a longer time. Adherence can also slow the development of drug resistance, and this is especially important in patients with early HIV infection who are just beginning treatment. However, anti-HIV medication schedules are often complicated, and many patients have difficulty remembering to take their drugs at the correct time. This study will look at the effectiveness of a plan to help patients with this problem.

Timeline

Start
—
Primary completion
2003-10
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Background Didanosine Small molecule — —
Background Efavirenz Other / unclassified — —
Background Nelfinavir Other / unclassified — —
Background Stavudine Other / unclassified — —